BIO.News Newsletter

A new BIO report outlines the state of early-stage funding for biotechs. Plus, during BIO 2025, legal experts unpacked IRA litigation—here’s what you should know. (761 words, 3 minutes, 48 seconds)

BIO hit the American road again, this time to Richmond, VA to meet with Virginia Bio, local entrepreneurs and patient advocates, and a company that's reshoring production of advanced pharmaceutical ingredients. Plus a look back at BIO 2025 conversations on IP and AMR. (662 words, 3 minutes, 18 seconds)

We hope you enjoyed the July break. We're back with a look at a new measles record, and what BIO's saying about the One, Big, Beautiful Bill Act, drug patents, and more. (873 words, 4 minutes, 21 seconds)

A busy week on Capitol Hill brought BIO Board member testimony and developments on issues where BIO’s advocacy remains hyper-focused, including PPRV, ORPHAN Cures, and vaccination. Plus, ACIP stirs concerns, and the BIOTech Caucus launches. (855 words, 4 minutes, 16 seconds)We'll take a break next Monday for the holiday weekend. We'll be back Monday July 14.

Today we look at why the Pediatric Priority Review Voucher needs to be reauthorized, and how global collaboration can lead us to the "biological century." (640 words, 3 minutes, 12 seconds)

That's a wrap. As we travel home from Boston, we take a look at why we do what we do – and hear from patient advocates who inspire us. Keep an eye on Bio.News for continued coverage all summer long, and catch up on the conversation on LinkedIn or your favorite social media platform with #BIO2025. (607 words, 3 minutes, 2 seconds)

It's Day 4. We recap a few impactful sessions exploring why patients – including rare disease patients and women – can't wait. Today, we close out with a look at how we can ensure the virtuous cycle of innovation continues. (786 words, 3 minutes, 55 seconds)

Day 2 brought current and former lawmakers at the federal and state levels to discuss how policy can advance progress. On Day 3, it's all about the patients. (804 words, 4 minutes, 1 seconds)

Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key to advancing AI, how the new BIO Partnering system is setting records. On Day 2, speakers including FDA Commissioner Dr. Martin Makary, M.D., Pennsylvania Gov. Josh Shapiro, and international health and science ministers will discuss how policy can support biotech innovation. (873 words, 4 minutes, 21 seconds)

The 2025 BIO International Convention kicks off today in Boston—and the Bio.News team is on the ground, bringing you all the news and highlights. Here’s what we’re watching and how to follow. (966 words, 4 minutes, 49 seconds)